Back
TransMedics Group Quote, Financials, Valuation and Earnings
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Buy
65
TMDX
TransMedics Group
Last Price:
166.00
Seasonality Move:
-0.45%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pmTransMedics Group Price Quote
$166.00
+10.05 (+6.44%)
(Updated: September 19, 2024 at 6:55 PM ET)
TransMedics Group Key Stats
Buy
65
TransMedics Group (TMDX)
is a Buy
Day range:
$152.59 - $160.57
52-week range:
$36.42 - $177.37
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
14.70
P/B ratio:
27.36%
Volume:
565.2K
Avg. volume:
810.3K
1-year change:
164.64%
Market cap:
$5.2B
Revenue:
$241.6M
EPS:
$0.04
How Much Does TransMedics Group Make?
-
How Much Are TransMedics Group's Sales Annually?
TMDX Revenues are $241.6M -
How Much Profit Does TransMedics Group's Make A Year?
TMDX net income is -$25M
Is TransMedics Group Growing As A Company?
-
What Is TransMedics Group's Growth Rate Quarterly?
Quarterly YoY revenue growth is 1.18% -
What Is TransMedics Group's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
TransMedics Group Stock Price Performance
-
Did TransMedics Group Stock Go Up Last Month?
TransMedics Group share price went down by -8.42% last month -
Did TMDX's Share Price Rise Over The Last Year?
TMDX share price rose by 164.64% over the past 1 year
What Is TransMedics Group 52-Week High & Low?
-
What Is TransMedics Group’s 52-Week High Share Price?
TransMedics Group has traded as high as $177.37 over the past 52 weeks -
What Is TransMedics Group’s 52-Week Low Share Price?
TransMedics Group has traded as low as $36.42 over the past 52 weeks
TransMedics Group Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy TransMedics Group?
-
How Much Debt Does TransMedics Group Have?
Total long term debt quarterly is $507.8M -
How Much Cash Does TransMedics Group Have?
Cash and short term investments quarterly total is $362.8M -
What Is TransMedics Group’s Book Value Per Share?
Book value per share is 5.70
Is TransMedics Group Cash Flow Positive?
-
What Is TMDX Cash Flow From Operations?
Cash flow from operations (TTM) is $23.7M -
What Is TransMedics Group’s Cash Flow From Financing?
Cash flow from financing (TTM) is $16.3M -
What Is TransMedics Group’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$259.6M
TransMedics Group Return On Invested Capital
-
Is Management Doing A Good Job?
TMDX return on invested capital is 0.46% -
What Is TransMedics Group Return On Assets?
ROA measures how assets are converting to revenues and is 0.42% -
What Is TMDX Return On Equity?
ROE is a measure of profitability and is 1.98%
TransMedics Group Earnings Date & Stock Price
-
What Is TransMedics Group's Stock Price Today?
A single share of TMDX can be purchased today for 155.95 -
What Is TransMedics Group’s Stock Symbol?
TransMedics Group trades on the nasdaq under the ticker symbol: TMDX -
When Is TransMedics Group’s Next Earnings Date?
The next quarterly earnings date for TransMedics Group is scheduled on November 6, 2024 -
When Is TMDX's next ex-dividend date?
TransMedics Group's next ex-dividend date is May 26, 2020 -
How To Buy TransMedics Group Stock?
You can buy TransMedics Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
TransMedics Group Competitors
-
Who Are TransMedics Group's Competitors?
Below is a list of companies who compete with TransMedics Group or are related in some way:
TransMedics Group Dividend Yield
-
What Is TMDX Dividend Yield?
TransMedics Group’s dividend yield currently is 0% -
What Is TransMedics Group’s Payout Ratio?
TransMedics Group’s payout ratio is 0% -
When Did TransMedics Group Last Pay A Dividend?
The latest dividend pay date is September 20, 2024 -
What Is TransMedics Group’s Dividend Per Share?
TransMedics Group pays a dividend of $0.00 per share
TransMedics Group Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 71.55% |
| Revenue: | 117.87% | 15.51% |
Analyst Recommendations
| Buy Recommendations: | 4 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 179.63 |
| Upside from Last Price: | 15.18% |